Keyphrases
Neuroblastoma
88%
131I-metaiodobenzylguanidine
60%
123I-MIBG
49%
Newly Diagnosed
40%
Positron Emission Tomography
26%
123I-MIBG Scintigraphy
20%
Nuclear Imaging
20%
Retrospective Analysis
20%
18F-FDG Positron Emission Tomography
20%
Pediatric Oncology
20%
Localized Neuroblastoma
20%
Single-photon Emission Computed Tomography (SPECT)
17%
Organ Function
16%
Diagnostic Accuracy
15%
Chemotherapy
14%
FDG Positron Emission Tomography/computed Tomography
12%
Positron Emission Tomography-computed Tomography (PET-CT)
11%
Metastasis
8%
Respiratory Function
8%
Progressive Disease
8%
Complete Response
8%
Acute Toxicity
7%
Scintigraphy
7%
Nuclear Medicine
6%
18 Years Old
5%
First Diagnosis
5%
Treatment Modalities
5%
Computed Tomography
5%
Partial Response
5%
Very Good Partial Response
5%
Fixed-dose Combination
5%
Primary Tumor
5%
Myeloablative Therapy
5%
Medicine and Dentistry
Ganglioneuroblastoma
100%
(3 Iodobenzyl)guanidine
60%
Iodine 131
55%
Iodine 123
30%
Positron Emission Tomography
26%
Fluorodeoxyglucose F 18
23%
Scintigraphy
20%
Nuclear Medicine
20%
Childhood Cancer
20%
Diagnostic Accuracy
12%
Chemotherapy
11%
Positron Emission Tomography-Computed Tomography
10%
Metastatic Carcinoma
9%
Recurrent Disease
7%
Fluorine-18
7%
Single-Photon Emission Computed Tomography
7%
Retrospective Study
7%
Single Photon Emission Computed Tomography-Computed Tomography
7%
Acute Toxicity
7%
Radioactive Tracer
6%
Computer Assisted Tomography
6%
Neoplasm
5%
Stem Cell
5%
Respiratory Physiology
5%
Progressive Disease
5%
Disease
5%